A great announcement released last week on the Qbiotics website...

  1. 683 Posts.
    lightbulb Created with Sketch. 120
    A great announcement released last week on the Qbiotics website that human clinical trial (QB46C-H07) has recruited all patients for its Phase 2A Soft tissue sarcoma, with the final patient being administered Tigilanol Tiglate.

    They expect that results will be released early 2025.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.